申请人:Boehringer Ingelheim International GmbH
公开号:US20150291607A1
公开(公告)日:2015-10-15
The present invention encompasses compounds of the formula (I)
wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
本发明涵盖了公式(I)的化合物,其中变量如本文所定义,适用于调节RORγ和治疗与调节RORγ相关的疾病。本发明还涵盖了制备公式(I)化合物的过程和含有它们的制药制剂。